C3 modified at the thiolester site: Acquisition of reactivity with cellular C3b receptors
- 1 November 1981
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 1 (11) , 873-880
- https://doi.org/10.1007/bf01114821
Abstract
Isolated human C3 [complement component 3] protein variable affinity for cellular C3b receptors. The question was investigated as to whether native C3 or a derivative form of the protein exhibits receptor affinity. Native C3 apparently lacks the ability to react with C3b receptors. C3 modified at the thiolester site, either by treatment with chaotropic agents or methylamine or by freezing and thawing, expressed inhibitory activity in the C3b-mediated rosetting assay or immune adherence. The extent of inhibition was comparable to that caused by C3b. The ability of modified C3 to react with cellular C3b receptors constitutes an additional functional property of C3b-like C3.This publication has 32 references indexed in Scilit:
- Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.The Journal of Experimental Medicine, 1981
- Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.The Journal of Experimental Medicine, 1981
- Treatment of Human Complement Components C4 and C3 with Amines or Chaotropic IonsScandinavian Journal of Immunology, 1981
- Third component of human complement: structural requirements for its functionBiochemistry, 1980
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.The Journal of Experimental Medicine, 1975
- RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLSThe Journal of Experimental Medicine, 1974
- Human Monocytes: Distinct Receptor Sites for the Third Component of Complement and for Immunoglobulin GScience, 1968
- Complement dependent immune phagocytosis: I. Requirements for C′1, C′4, C′2, C′3Experimental Cell Research, 1968